Research Articles & Publications
A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias
Published on 26 July 2024
Brain Ethanolamine Phospholipids, Neuropathology and Cognition: A Comparative Post-Mortem Analysis of Structurally Specific Plasmalogen and Phosphatidyl Species
Published on 24 August 2022
Targeted plasmalogen supplementation: Effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons
Published on 06 July 2022
Plasmalogen Deficiency: A Risk Factor for Dementias and Potential Treatment Target
Published on 05 May 2022
The effect of plasmalogen precursor supplementation on blood catalase and malondialdehyde levels in cognitively impaired persons
Published on 31 December 2021
The effect of plasmalogen precursor supplementation on blood plasmalogen and C-reactive protein levels and cognition in cognitively impaired persons
Published on 31 December 2021
Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery—New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms
Published on 19 Auguest 2021
Breaking Alzheimer's: A 15 Year Crusade to Expose the Cause and Deliver the Cure
Published 2021
Circulating ethanolamine plasmalogen indices in Alzheimer’s disease: Relation to diagnosis, cognition, and CSF tau
Published on 27 July 2020
Altered ethanolamine plasmalogen and phosphatidyl-ethanolamine levels in blood plasma of patients with bipolar disorder
Published on 16 December 2019
ASSOCIATION OF SERUM‐BASED PLASMALOGENS WITH NEUROIMAGING AND GENETIC VARIATION IN ALZHEIMER'S DISEASE
Published on 01 July 2019
Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study
Published on 24 April 2019
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
Published on 01 January 2019
Serum Indices Of Ethanolamine Plasmalogens And Phosphatide Metabolism In The Combined ADNI-1/GO/2 Cohort: Does The Liver Contribute To Alzheimer's Disease (AD) Risk By Failing To Supply Key Lipids To The Brain?
Published on 01 July 2018
Serum Long-Chain N-3 Fatty Acid Levels Are Associated With Presynaptic Proteins In The Human Brain
Published on 01 July 2017
Serum Metabolite Profiling for the Detection of Pancreatic Cancer: Results of a Large Independent Validation Study
Published on 01 November 2016
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice (Parkinson's Disease)
Published on 09 March 2016
Metabolic Dysfunctions in Multiple Sclerosis: Implications as to Causation, Early Detection, and Treatment, a Case-Control Study
Published on 27 August 2015
Pancreatic Cancer Serum Biomarker PC-594: Diagnostic Performance and Comparison to CA19-9
Published on 07 June 2015
Plasmalogen Precursor Analog Treatment Reduces Levodopa-Induced Dyskinesias in Parkinsonian Monkeys
Published on 01 June 2015
Metabolic System Alterations in Pancreatic Cancer Patient Serum: Potential for Early Detection
Published on 12 September 2013
Low-Serum GTA-446 Anti-Inflammatory Fatty Acid Levels as a New Risk Factor for Colon Cancer
Published on 14 June 2012
Oral Bioavailability of the Ether Lipid Plasmalogen Precursor, PPI-1011, in the Rabbit: A New Therapeutic Strategy for Alzheimer’s Disease
Published on 05 December 2011
Human Serum-Derived Hydroxy Long-Chain Fatty Acids Exhibit Anti-Inflammatory and Anti-Proliferative Activity
Published on 17 May 2011
Reduction of Novel Circulating Long-chain Fatty Acids in Colorectal Cancer Patients is Independent of Tumor Burden and Correlates With Age
Published on 29 November 2010
Reduced Levels of Hydroxylated, Polyunsaturated Ultra Long-Chain Fatty Acids in the Serum of Colorectal Cancer Patients: Implications for Early Screening and Detection
Published on 15 February 2010
Circulating Plasmalogen Levels and Alzheimer Disease Assessment Scale-Cognitive Scores in Alzheimer Patients
Published on 01 January 2010
Novel Plasma Phospholipid Biomarkers of Autism: Mitochondrial Dysfunction as a Putative Causative Mechanism
Published on 25 August 2009
Peripheral Ethanolamine Plasmalogen Deficiency: A Logical Causative Factor in Alzheimer's Disease and Dementia
Published on 02 August 2007